GSK and Save the Children renew award-winning partnership, with focus on 'zero dose' children who have never received a vaccine
- Details
- Category: GlaxoSmithKline

Roche's Alecensa delivers unprecedented Phase III results for people with ALK-positive early-stage lung cancer
- Details
- Category: Roche

BlueRock's Phase I study with bemdaneprocel in patients with Parkinson's disease meets primary endpoint
- Details
- Category: Bayer

Novartis completes acquisition of Chinook Therapeutics
- Details
- Category: Novartis

U.S. FDA Approves ABRYSVO™, Pfizer's vaccine for the prevention of respiratory syncytial virus (RSV) in infants through active immunization of pregnant individuals 32-36 weeks of gestational age
- Details
- Category: Pfizer

Mahana Therapeutics signs agreement with Consumer Health division of Bayer to commercialize digital therapeutics
- Details
- Category: Bayer

AbbVie announces European Commission approval of AQUIPTA® (atogepant) for the preventive treatment of migraine in adults
- Details
- Category: AbbVie

More Pharma News ...
- Pfizer's ELREXFIO™ receives U.S. FDA accelerated approval for relapsed or refractory multiple myeloma
- Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years
- Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries
- New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria
- AI drives new era of target identification and drug design
- Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
- Pfizer announces executive leadership to advance oncology research and development strategy